Inactive

Solicitation Number: 75N95024Q00031 Title: Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand Name or Equal) Classification Code: 6640-LABORATORY EQUIPMENT AND SUPPLIES NAICS Code:... Solicitation Number: 75N95024Q00031 Title: Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand Name or Equal) Classification Code: 6640-LABORATORY EQUIPMENT AND SUPPLIES NAICS Code: 334516- Analytical Laboratory Instrument Manufacturing Size Standard: 1,000 employees Description: Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand name or equal) for software-controlled flow. Includes Biochip Frame P Vena8 for Revolve Microscope, Glass Syringe for pump, and tubing kit, power supply and cables. Training and 2 sets of consumables (20 assays) will be included. One year warranty included. This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement, to determine the method of acquisition, and availability of domestic sources manufactured in the United States in sufficient and reasonably available commercial quantities and of a satisfactory quality. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Small businesses are encouraged to respond. For equipment/supply requirements, responses must include the place of manufacturing (i.e. address if supply/equipment is a domestic end product and include country of manufacture). For equipment/supply requirements, small businesses must also address the size status of the manufacturer under the applicable NAICS code (i.e. address Non-Manufacturer Rule). Background: The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting, and making medical discoveries that improve people’s health and save lives. The cardiovascular working group of Tox21 is exploring the effects of exposure brought about by environmental, pharmaceutical, and other means in controlled human cellular models. NCATS has performed a search for an apparatus that can facilitate the measurement of thrombosis/clotting in a human vascular cell model in a quantitative and reproduceable manner suitable for higher throughput. Purpose and Objectives: Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand name or equal) for software-controlled flow. Includes Biochip Frame P Vena8 for Revolve Microscope, Glass Syringe for pump, and tubing kit, power supply and cables. Training and 2 sets of consumables (20 assays) will be included. One year warranty included. Project requirements: Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand name or equal) for software-controlled flow. Includes Biochip Frame P Vena8 for Revolve Microscope, Glass Syringe for pump, and tubing kit, power supply and cables. Training and 2 sets of consumables (20 assays) will be included. One year warranty included. Salient characteristics: The Venaflux Starter kit will include all parts necessary for semiautomated flow-controlled thrombosis/coagulation assays with cultured cells that can be viewed and assayed through a computer connected to an Echo Revolve microscope (microscope is already part of NCATS inventory). Thrombosis, Platelet Adhesions and Aggregation Assays: 2.25 - 450 dyne/cm with Vena8 Fluoro+ Biochips Cell-ligand & Cell-Cell Rolling, Adhesion & Migration Sear Flow Assays: 0.05 - 10 dyne/cm Multiplexed Assays providing equal flow rates in 8 channels of biochips. This enables multiple cell types or adhesion molecules to be tested simultaneously comparing different therapeutic treatments. Temperature controlled conditions mimicking physiological conditions with microenvironmental chamber. Cell analysis of % thrombus coverage and number of thrombi: number of cells adhered to protein-coated channels and analysis of rolling velocities of cells Programmable with PC controlled software enabling executing of customize protocols. Included one year warranty. Delivery Quantity: One kit with 2 consumable items packages Quantity 1- Cellix Venaflux Starter 1.0 with Mirus Evo Pump with multiflow8 (Brand Name or Equal) Quantity 2-Consumable items packages Training for the Assay Device Delivery Anticipated period of performance: 30 days after order is placed Other important considerations: Cite any other information that is necessary for potential respondents to understand the nature of the potential requirement or proposed acquisition. In case domestic sources are available and capable of fulfilling the Government’s need, and a future solicitation is published, the Government will use evaluation preferences in accordance with FAR 25. Capability statement /information sought. Companies that believe they possess the capabilities to provide the required products or services should submit documentation of their ability to meet each of the project requirements to the Contracting Officer. The capability statement must specifically address each of the project requirements separately. Additionally, the capability statement should include 1) the total number of employees, 2) the professional qualifications of personnel as it relates to the requirements outlined, 3) any contractor GSA Schedule contracts and/or other government-wide acquisition contracts (GWACs) by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Capability statements must also include the Company Name, Unique Entity ID from SAM.gov, Physical Address, and Point of Contact Information. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. Interested companies are required to identify their type of business, applicable North American Industry Classification System (NAICS) Code, and size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number. One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing. The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Maggie Brant at e-mail address maggie.brant@nih.gov. The response must be received on or before November 27, 2023, 4:00 pm, Eastern Time. “Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in www.sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).”